CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype

Kyu Sub Kang, Yoon Pyo Choi, Ming Qing Gao, Suki Kang, Baek Gil Kim, Joo Hyun Lee, Mi Jeong Kwon, Young Kee Shin, Namhoon Cho

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

We recently reported that the subset of CD24+ cells in ovarian cancer possesses various cancer stem cell properties. In this study, we further show that this subpopulation of ovarian cancer cells exhibits an epithelial-mesenchymal transition (EMT) phenotype, high invasive capacity, and CXCR4/SDF-1-mediated chemotactic migration. We evaluated CD24 expression in various ovarian cancer cell lines by flow cytometric analysis. CAOV3 and a primary ovarian cancer cell line Clone 4 were sorted into CD24+ and CD24- subpopulations by FACS and Western blot, cell invasion, adhesion, and in vitro chemotaxis assays were performed with these two subpopulations. We also assessed the effects of shRNA depletion of CD24 in CAOV3 and Clone 4 cells by Western blot and cell invasion assays. CD24 expression in ovarian cancer cell lines correlated with aggressive histologic subtypes of epithelial ovarian cancer. The CD24+ subpopulation was also more invasive than the CD24- subpopulation and showed higher CXCR4/SDF-1-mediated chemotactic migration. CD24+ cells exhibited an EMT phenotype as characterized by loss of E-cadherin expression and gain of vimentin, Twist, and Snail1 expression. In addition, CD24+ cells stimulated cell attachment to fibronectin through the activation of β1 integrin. Depletion of CD24 expression by CD24 shRNA efficiently suppressed cell invasion and induced downregulation of CXCR4 as well as loss of the EMT phenotype. In conclusion, CD24 expression in ovarian cancer may be related to tumor aggressiveness, in particular cell invasion and chemotactic migration. Therefore, CD24 may be a good candidate for a therapeutic target for ovarian cancer.

Original languageEnglish
Pages (from-to)333-338
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume432
Issue number2
DOIs
Publication statusPublished - 2013 Mar 8

Fingerprint

Ovarian Neoplasms
Cells
Phenotype
Small Interfering RNA
Epithelial-Mesenchymal Transition
Assays
Cell adhesion
Vimentin
Cadherins
Stem cells
Fibronectins
Integrins
Cell Line
Tumors
Clone Cells
Western Blotting
Chemical activation
Neoplastic Stem Cells
Chemotaxis
Cell Adhesion

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Kang, Kyu Sub ; Choi, Yoon Pyo ; Gao, Ming Qing ; Kang, Suki ; Kim, Baek Gil ; Lee, Joo Hyun ; Kwon, Mi Jeong ; Shin, Young Kee ; Cho, Namhoon. / CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype. In: Biochemical and Biophysical Research Communications. 2013 ; Vol. 432, No. 2. pp. 333-338.
@article{4aa52bbf3f9946a795aaf51f04c67f79,
title = "CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype",
abstract = "We recently reported that the subset of CD24+ cells in ovarian cancer possesses various cancer stem cell properties. In this study, we further show that this subpopulation of ovarian cancer cells exhibits an epithelial-mesenchymal transition (EMT) phenotype, high invasive capacity, and CXCR4/SDF-1-mediated chemotactic migration. We evaluated CD24 expression in various ovarian cancer cell lines by flow cytometric analysis. CAOV3 and a primary ovarian cancer cell line Clone 4 were sorted into CD24+ and CD24- subpopulations by FACS and Western blot, cell invasion, adhesion, and in vitro chemotaxis assays were performed with these two subpopulations. We also assessed the effects of shRNA depletion of CD24 in CAOV3 and Clone 4 cells by Western blot and cell invasion assays. CD24 expression in ovarian cancer cell lines correlated with aggressive histologic subtypes of epithelial ovarian cancer. The CD24+ subpopulation was also more invasive than the CD24- subpopulation and showed higher CXCR4/SDF-1-mediated chemotactic migration. CD24+ cells exhibited an EMT phenotype as characterized by loss of E-cadherin expression and gain of vimentin, Twist, and Snail1 expression. In addition, CD24+ cells stimulated cell attachment to fibronectin through the activation of β1 integrin. Depletion of CD24 expression by CD24 shRNA efficiently suppressed cell invasion and induced downregulation of CXCR4 as well as loss of the EMT phenotype. In conclusion, CD24 expression in ovarian cancer may be related to tumor aggressiveness, in particular cell invasion and chemotactic migration. Therefore, CD24 may be a good candidate for a therapeutic target for ovarian cancer.",
author = "Kang, {Kyu Sub} and Choi, {Yoon Pyo} and Gao, {Ming Qing} and Suki Kang and Kim, {Baek Gil} and Lee, {Joo Hyun} and Kwon, {Mi Jeong} and Shin, {Young Kee} and Namhoon Cho",
year = "2013",
month = "3",
day = "8",
doi = "10.1016/j.bbrc.2013.01.102",
language = "English",
volume = "432",
pages = "333--338",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

Kang, KS, Choi, YP, Gao, MQ, Kang, S, Kim, BG, Lee, JH, Kwon, MJ, Shin, YK & Cho, N 2013, 'CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype', Biochemical and Biophysical Research Communications, vol. 432, no. 2, pp. 333-338. https://doi.org/10.1016/j.bbrc.2013.01.102

CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype. / Kang, Kyu Sub; Choi, Yoon Pyo; Gao, Ming Qing; Kang, Suki; Kim, Baek Gil; Lee, Joo Hyun; Kwon, Mi Jeong; Shin, Young Kee; Cho, Namhoon.

In: Biochemical and Biophysical Research Communications, Vol. 432, No. 2, 08.03.2013, p. 333-338.

Research output: Contribution to journalArticle

TY - JOUR

T1 - CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype

AU - Kang, Kyu Sub

AU - Choi, Yoon Pyo

AU - Gao, Ming Qing

AU - Kang, Suki

AU - Kim, Baek Gil

AU - Lee, Joo Hyun

AU - Kwon, Mi Jeong

AU - Shin, Young Kee

AU - Cho, Namhoon

PY - 2013/3/8

Y1 - 2013/3/8

N2 - We recently reported that the subset of CD24+ cells in ovarian cancer possesses various cancer stem cell properties. In this study, we further show that this subpopulation of ovarian cancer cells exhibits an epithelial-mesenchymal transition (EMT) phenotype, high invasive capacity, and CXCR4/SDF-1-mediated chemotactic migration. We evaluated CD24 expression in various ovarian cancer cell lines by flow cytometric analysis. CAOV3 and a primary ovarian cancer cell line Clone 4 were sorted into CD24+ and CD24- subpopulations by FACS and Western blot, cell invasion, adhesion, and in vitro chemotaxis assays were performed with these two subpopulations. We also assessed the effects of shRNA depletion of CD24 in CAOV3 and Clone 4 cells by Western blot and cell invasion assays. CD24 expression in ovarian cancer cell lines correlated with aggressive histologic subtypes of epithelial ovarian cancer. The CD24+ subpopulation was also more invasive than the CD24- subpopulation and showed higher CXCR4/SDF-1-mediated chemotactic migration. CD24+ cells exhibited an EMT phenotype as characterized by loss of E-cadherin expression and gain of vimentin, Twist, and Snail1 expression. In addition, CD24+ cells stimulated cell attachment to fibronectin through the activation of β1 integrin. Depletion of CD24 expression by CD24 shRNA efficiently suppressed cell invasion and induced downregulation of CXCR4 as well as loss of the EMT phenotype. In conclusion, CD24 expression in ovarian cancer may be related to tumor aggressiveness, in particular cell invasion and chemotactic migration. Therefore, CD24 may be a good candidate for a therapeutic target for ovarian cancer.

AB - We recently reported that the subset of CD24+ cells in ovarian cancer possesses various cancer stem cell properties. In this study, we further show that this subpopulation of ovarian cancer cells exhibits an epithelial-mesenchymal transition (EMT) phenotype, high invasive capacity, and CXCR4/SDF-1-mediated chemotactic migration. We evaluated CD24 expression in various ovarian cancer cell lines by flow cytometric analysis. CAOV3 and a primary ovarian cancer cell line Clone 4 were sorted into CD24+ and CD24- subpopulations by FACS and Western blot, cell invasion, adhesion, and in vitro chemotaxis assays were performed with these two subpopulations. We also assessed the effects of shRNA depletion of CD24 in CAOV3 and Clone 4 cells by Western blot and cell invasion assays. CD24 expression in ovarian cancer cell lines correlated with aggressive histologic subtypes of epithelial ovarian cancer. The CD24+ subpopulation was also more invasive than the CD24- subpopulation and showed higher CXCR4/SDF-1-mediated chemotactic migration. CD24+ cells exhibited an EMT phenotype as characterized by loss of E-cadherin expression and gain of vimentin, Twist, and Snail1 expression. In addition, CD24+ cells stimulated cell attachment to fibronectin through the activation of β1 integrin. Depletion of CD24 expression by CD24 shRNA efficiently suppressed cell invasion and induced downregulation of CXCR4 as well as loss of the EMT phenotype. In conclusion, CD24 expression in ovarian cancer may be related to tumor aggressiveness, in particular cell invasion and chemotactic migration. Therefore, CD24 may be a good candidate for a therapeutic target for ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=84875269869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875269869&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2013.01.102

DO - 10.1016/j.bbrc.2013.01.102

M3 - Article

VL - 432

SP - 333

EP - 338

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -